Skip to main content
Livermore
Livermore
ZHEN

Vertex Pharmaceuticals Inc

VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000875320

In the last 90 days, Vertex Pharmaceuticals Inc insiders filed 0 open-market purchases and 3 sales; 1,763 institutions reported holding it in 13F filings for Q2 2026, worth $119.7B in total; no superinvestor holds it.

Superinvestors holding VRTX, Q2 2026

See all superinvestors

No superinvestor reported holding VRTX in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of VRTX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q1 2026

    0 superinvestors holding at quarter end

    Sold out
    ARK Invest

  2. Q4 2025

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+1.7%)

  3. Q3 2025

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+6.7%)

  4. Q2 2025

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−8.7%)

  5. Q1 2025

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+3.9%)

  6. Q4 2024

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−50.4%)

  7. Q3 2024

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−32.3%)

  8. Q2 2024

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−16.2%)

  9. Q1 2024

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−27.5%)
    Sold out
    Maverick Capital

  10. Q4 2023

    2 superinvestors holding at quarter end

    Added
    ARK Invest (+7.7%)
    Reduced
    Maverick Capital (−44.3%)

  11. Q3 2023

    2 superinvestors holding at quarter end

    New
    Maverick Capital
    Reduced
    ARK Invest (−0.3%)

  12. Q2 2023

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−4.0%)

  13. Q1 2023

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−1.4%)

  14. Q4 2022

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−22.4%)

  15. Q3 2022

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−56.9%)

  16. Q2 2022

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−13.3%)

  17. Q1 2022

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−54.6%)

  18. Q4 2021

    1 superinvestor holding at quarter end

    Reduced
    ARK Invest (−45.7%)
    Sold out
    Maverick Capital

  19. Q3 2021

    2 superinvestors holding at quarter end

    New
    Maverick Capital
    Reduced
    ARK Invest (−3.6%)

  20. Q2 2021

    1 superinvestor holding at quarter end

    Added
    ARK Invest (+3.2%)
    Sold out
    Maverick Capital